• Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet

ISDB – International Society of Drug Bulletins

International Society of Drug Bulletins

  • Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet
  • Menu

Therapeutics Initiative

March 5, 2010

Evidence-based Drug Therapy

Referent: Alan Cassels
Address: 2176 Health Sciences Mall
City: Vancouver, BC, V6T 1Z3 – Canada
Phone: 1 604 822 0700
Mobile: 1 250 508 8996
Fax: 1 604 822 0701
E-mail: alan.cassels@ti.ubc.ca
Website: www.ti.ubc.ca/

Recent Publications

  • ISDB response to the public consultation on the Clinical Trials Regulation and its information system
  • ISDB Newsletter April 2023
  • Information on Covid-19
  • Response letter of the Australian Health Minister in follow-up of ISDB mobilization in support of Australian Prescriber
  • News on Covid-19

Newsletter

Recent Campaigns

  • Letter to the Australian Health Minister in support of Australian Prescriber
  • Letter to Charles Michel on transparency in EU institutions
  • A letter to the Prime Minister of India
  • ISDB General Assembly Paris 2019
  • News from working groups: Clinical Study Reports?

Contact

President
Rita Kessler
president@isdbweb.org

Webmaster
deToon
tjvandort@gmail.com

Sign up to receive our newsletter.

Press releases

  • Statement: COVID-19 [EN]
  • ISDB General Assembly Paris 2019
  • Cochrane’s sinking ship and conflicts of interest
  • No to EMA’s provision of confidential scientific advice to drug companies (November 2017)
  • Supplementary protection certificates (SPCs) delay access to affordable medicines (September 2017)

Newsletters

  • ISDB Newsletter April 2023
  • ISDB Newsletter September 2022
  • ISDB Newsletter December 2021
  • ISDB Newsletter August 2021
  • ISDB Newsletter May 2021

© 2023 ISDB – International Society of Drug Bulletins.